Browsing by Author Schuchter, Lynn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2015Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trialKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Ashworth, Michelle T; et al, Various; Flaherty, Keith; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, K B; Schuchter, Lynn; Swann, S; Weber, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineCharacteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trial, Annals of Oncology, vol.26, 2, 2015,pp 415-421
2014Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitorKefford, Richard (Rick); Long, Georgina; Cebon, Jonathan Simon; et al, Various; Flaherty, Keith; Hamid, Omid; Infante, Jeffrey; Johnson, Douglas B; Kim, Kevin; McWilliams, Robert; Schuchter, Lynn; Sharfman, William; Weber, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreCombined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor, Journal of Clinical Oncology, vol.32, 33, 2014,pp 3697-3704
2016Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With TrametinibKefford, Richard (Rick); Long, Georgina; Cebon, Jonathan Simon; Daud, Adil; et al, .; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, Kevin B; Schuchter, Lynn; Sosman, Jeffrey; Weber, Jeffrey; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer CentreOverall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib, Journal of Clinical Oncology, vol.34, 8, 2016,pp 871-878
2016Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With TrametinibKefford, Richard (Rick); Long, Georgina; Cebon, Jonathan Simon; Daud, Adil; et al, .; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, Kevin B; Schuchter, Lynn; Sosman, Jeffrey; Weber, Jeffrey; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer CentreOverall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib, Journal of Clinical Oncology, vol.34, 8, 2016,pp 871-878
2013Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic MelanomaHersey, Peter; Long, Georgina; et al, Various; Flaherty, Keith; Gonzalez, Rene; Hutson, Thomas; Kim, Kevin; McArthur, Grant A.; Moschos, Stergios; Pavlick, Anna C.; Schuchter, Lynn; Trunzer, Kerstin; Weber, Jeffrey; Northern Clinical School: Surgery; Central Clinical School: The Sydney Cancer CentrePharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma, Journal of Clinical Oncology, vol.31, 14, 2013,pp 1767-1774
2013Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic MelanomaKefford, Richard (Rick); Atkins, Michael B.; Flaherty, Keith T; Flaherty, Lawrence; Kirkwood, John M; Lee, Sandra J; Leming, Philip; Schuchter, Lynn; Zhao, Fengmin; Western Clinical School: Westmead Millennium InstitutePhase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma, Journal of Clinical Oncology, vol.31, 3, 2013,pp 373-379
2012Survival in BRAF V600-mutant advanced melanoma treated with vemurafenibHersey, Peter; Kefford, Richard (Rick); et al, Various; Flaherty, Keith; Gonzalez, Rene; Hutson, Thomas; Kim, Kevin; McArthur, Grant A.; Moschos, Stergios; Pavlick, Anna C.; Schuchter, Lynn; Sosman, Jeffrey; Weber, Jeffrey; Northern Clinical School: Surgery; Western Clinical School: Westmead Millennium InstituteSurvival in BRAF V600-mutant advanced melanoma treated with vemurafenib, New England Journal of Medicine, vol.366, 8, 2012,pp 707-714